Comparison between Ganga Pharmaceuticals IPO and Wealth First Portfolio IPO.
Ganga Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Wealth First Portfolio IPO is a SME Fixed Price proposed to list at NSE SME.
| Ganga Pharmaceuticals IPO | Wealth First Portfolio IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | First Overseas Capital Ltd. | Sarthi Capital Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Alacrity Securities Ltd. | Innovate Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the Wealth First Portfolio IPO is up to ₹8.00 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of Wealth First Portfolio IPO is ₹50.00 per share.
| Ganga Pharmaceuticals IPO | Wealth First Portfolio IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹15.00 per share | ₹50.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 3000 shares |
| Fresh Issue Size | 10,24,000 shares | 15,99,000 shares |
| Fresh Issue Size (Amount) | up to ₹1.54 Cr | up to ₹8.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 10,24,000 shares | 15,99,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹8.00 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while Wealth First Portfolio IPO opens on Mar 10, 2016. The closing date of Ganga Pharmaceuticals IPO and Wealth First Portfolio IPO is Feb 09, 2016, and Mar 18, 2016, respectively.
| Ganga Pharmaceuticals IPO | Wealth First Portfolio IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Mar 10, 2016 |
| Issue Close | Feb 09, 2016 | Mar 18, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 22, 2016 | Mar 30, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to Wealth First Portfolio IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | Wealth First Portfolio IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 91.05 | |
| Promoter Shareholding (Post-Issue) | 68.09 | |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27% |
In the Ganga Pharmaceuticals IPO Retail Individual Investors (RII) are offered 5,12,000 shares while in Wealth First Portfolio IPO retail investors are offered 5,12,000 shares. Qualified Institutional Buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in Wealth First Portfolio IPO.
| Ganga Pharmaceuticals IPO | Wealth First Portfolio IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 0 shares | 84,000 shares |
| QIB | ||
| NII | 5,12,000 shares | 7,98,000 shares |
| RII | 5,12,000 shares | 7,98,000 shares |
| Employee | ||
| Others | ||
| Total | 10,24,000 shares | 15,96,000 shares |
Ganga Pharmaceuticals IPO subscribed in total, whereas Wealth First Portfolio IPO subscribed .
| Ganga Pharmaceuticals IPO | Wealth First Portfolio IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
